Method for producing meso-galactaric acid by contacting a fungal cell with a biomaterial having galacturonic acid

Patent metadata

Field	Value
Publication number	US-10982239-B2
Application number	US-201716302836-A
Country	US
Kind code	B2
Filing date	May 19, 2017
Priority date	May 20, 2016
Publication date	Apr 20, 2021
Grant date	Apr 20, 2021

Abstract

The present invention relates to a field of genetically modified fungal cells and converting galacturonic acid to meso-galactaric acid, more precisely to a method of producing meso-galactaric acid. The invention further relates to recombinant fungal cells having a specific combination of modifications including but not limited to expression of uronate dehydrogenase enzyme, reduced D-galacturonic acid reductase activity, and furthermore reduced meso-galactaric acid catabolism, as well as uses and methods related thereto.

First claim

The invention claimed is:

1. A method for producing meso-galactaric acid, said method comprising
contacting a fungal cell genetically modified to express uronate dehydrogenase enzyme, genetically modified to have reduced D-galacturonic acid reductase activity, and modified to reduce meso-galactaric acid catabolism by deleting at least part of a gene encoding JGI protein IDs: 39114 (SEQ ID No: 72), 1090836 (SEQ ID NO: 73) and/or 1121140 (SEQ ID NO: 74), with a biomaterial comprising galacturonic acid, and
recovering the resulting meso-galactaric acid.

2. A fungal cell that has been genetically modified to express uronate dehydrogenase enzyme, genetically modified to have reduced D-galacturonic acid reductase activity, and is capable of converting D-galacturonic acid to meso-galactaric acid, wherein said fungal cell has been further modified to reduce meso-galactaric acid catabolism by deleting at least part of a gene encoding JGI protein IDs: 39114 (SEQ ID No: 72), 1090836 (SEQ ID NO: 73) and/or 1121140 (SEQ ID NO: 74).

3. A method for treating biomaterial comprising galacturonic acid, which method comprises that a fungal cell genetically modified to express uronate dehydrogenase enzyme, genetically modified to have reduced D-galacturonic acid reductase activity, and modified to reduce mesogalactaric acid catabolism by deleting at least part of a gene encoding JGI protein IDs: 39114 (SEQ ID No: 72), 1090836 (SEQ ID NO: 73) and/or 1121140 (SEQ ID NO: 74), is contacted with said biomaterial under suitable culture conditions.

4. The method of claim 1 , wherein the fungal cell is a mould or filamentous fungus.

5. The method of claim 1 , wherein the fungal cell is from the genera Aspergillus, Hypocrea or Trichoderma.

6. The method of claim 1 , wherein the fungal cell is selected from the group consisting of Aspergillus niger, A. oryzae, A. terreus, A. nidulans, A. kawachii, A. fischeri and Trichoderma reesei.

7. The method of claim 1 , wherein the fungal cell is naturally capable of degrading pectin.

8. The method of claim 1 , wherein the uronate dehydrogenase enzyme is a heterologous uronate dehydrogenase enzyme.

9. The method of claim 1 , wherein the uronate dehydrogenase enzyme is D-galacturonate dehydrogenase enzyme.

10. The method of claim 1 , wherein a polynucleotide encoding D-galacturonic acid reductase has been deleted.

11. The method of claim 1 , wherein the fungal cell has further been genetically modified by deleting at least part of a polynucleotide encoding 2-keto-3-deoxy-L-galactonate aldolase.

12. The method of claim 1 , wherein the uronate dehydrogenase enzyme is a heterologous uronate dehydrogenase enzyme originating from Pseudomonas or Agrobacterium genera.

Assignees

• Teknologian Tutkimuskeskus Vtt Oy

Inventors

• Kuivanen Joosu
• Richard Peter
• Wang Ying-Mong Jasmin

Classifications

• C12R2001/885

  Trichoderma · CPC title

• C12R2001/69

  Aspergillus oryzae · CPC title

• C12R2001/685

  Aspergillus niger · CPC title

• C12N1/145

  Fungi isolates · CPC title

• C12Q1/26

  involving oxidoreductase · CPC title